Drug intelligence / Profile preview

proscillaridin a

Development stage
Unknown
Lead developer
Knoll
Modality
Small Molecules
Administration
Oral
01

Overview

Proscillaridin A is a cardiac glycoside of the bufadienolide class, naturally occurring in the squill plant (*Drimia maritima*). It is a potent inhibitor of the **Sodium/potassium-transporting ATPase (Na+/K+-ATPase)** pump. While historically used in Europe for the treatment of **congestive heart failure** and **cardiac arrhythmias**, recent research has focused on its repositioning as an anti-cancer agent. In **glioblastoma**, Proscillaridin A has been shown to induce GSK3β activation, which leads to the phosphorylation of the microtubule-plus-end-tracking protein EB1, resulting in altered microtubule dynamics, impaired cell migration, and selective cytotoxicity against tumor and stem-like cells.

Brand names
TalusinCaradrinSandoscill
Other names
ProscillaridinPSCProA
02

Targets

TOP2A (DNA topoisomerase II)STAT3 (Signal Transducer and Activator of Transcription 3)TOP1 (DNA Topoisomerase I)

Beyond the preview

Go deeper on proscillaridin a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proscillaridin a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call